A comprehensive view of Injectables/Infusions/IV Drips. This page highlights a small sample of our full coverage.
For real-time access, please log in to your R&D/Patents Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

German firm MorphoSys licenses drugs felzartamab injectable and MOR210 to US biotechnology firm Hibio for US$15M, 15% stake in Hibio; Hibio can develop, market the two drugs worldwide except for felzartamab in China, MOR210 in China, South Korea

FDA approves Rhythm Pharmaceuticals’ Imcivree setmelanotide injectable to treat obesity in patients with Bardet-Biedl syndrome; FDA did not approve drug for patients with Alstroem syndrome

Plus Therapeutics partners with Biocept to use Biocept’s CNSide cerebrospinal fluid assay in ReSPECT-LM Phase 1/2a clinical trial of injectable Rhenium-186 nanoLiposome to treat leptomeningeal metastases, a cancer of brain, spinal cord membranes

Eli Lilly supplying Aveo Oncology with Erbitux cetuximab for North American clinical trial evaluating Aveo’s ficlatuzumab with cetuximab to treat metastatic head, neck squamous cell carcinoma; Merck KGaA providing cetuximab outside of US, Canada

FDA approves Merck’s Vaxneuvance pneumococcal 15-valent conjugate vaccine for children ages 6 weeks to 17 years old; vaccine administered in four-dose series, provides superior immune response against pneumococcal serotype 3, unique serotypes 22F, 33F

Ask us about our R&D/Patents market view

Trending Chart

Interactive chart with headline count